Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegasys and Copegus for HCV recurrence after liver transplant
NCT00087633Phase 4Completed
- Sponsor
- Roche
- Start
- Oct 2004
- Primary completion
- Oct 2008
- Modality
- Orthosteric Ligands, Cytokines & Interferons, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of pegylated interferon alpha, ribavirin in hepatitis C virus infection, sponsored by Roche. Started Oct 2004; status: completed.
02
Drugs
pegylated interferon alpharibavirin
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT00087633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00087633.